Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Miyuki Eto"'
Autor:
Takako Minami, Koji Maemura, Tomoo Nakata, Seiji Koga, Katsunori Yanagihara, Akira Tsuneto, Sanae Kojima, Takeo Yoshida, Miyuki Eto, Satoshi Ikeda
Publikováno v:
Life sciences. 111(1-2)
Aims Echocardiography is widely used for screening pulmonary hypertension (PH). More recently developed two-dimensional speckle-tracking echocardiography (2D-STE) can assess regional deformation of the myocardium and is useful for detecting left vent
Autor:
Yuji Koide, Koji Maemura, Seiji Koga, Hiroaki Kawano, Takeo Yoshida, Miyuki Eto, Satoshi Ikeda, Tomoo Nakata
Publikováno v:
Journal of the American College of Cardiology. 63:A1583
Autor:
Tsuyoshi Shiga, Hiroshi Kasanuki, Takako Inaba, Kanji Sato, Satoshi Ohnishi, Miyuki Eto, Naoki Matsuda, Megumi Miyakawa
Publikováno v:
Endocrine journal. 46(3)
Since amiodarone was introduced in Japan in 1992, the incidence of the drug-induced thyroid dysfunction has been increasing. We studied the thyroid function of 13 patients with amiodarone-induced thyrotoxicosis (AIT) and 11 patients with amiodarone-a
Autor:
Koji Maemura, Takeo Yoshida, Satoshi Ikeda, Seiji Koga, Tomoo Nakata, Hiroaki Kawano, Miyuki Eto, Yuji Koide
Publikováno v:
Journal of the American College of Cardiology. 62:B91
Autor:
Miyuki Eto, Tomoaki Matsuo, Maeng-Kyu Kim, Miji Kim, Byungroh Kim, Hiroyuki Sasai, Kiyoji Tanaka, Yasuhiro Nomata
Publikováno v:
Medicine & Science in Sports & Exercise. 42:805
Autor:
Masao Aono, Yoshitaka Hara, Kuniko Yamada, Katsumasa Maeda, Akifumi Akamine, Miyuki Eto, Sachiko Miyatake
Publikováno v:
Nihon Shishubyo Gakkai kaishi. 31(1)
The purpose of this study was to evaluate the efficacy of porous hydroxyapatite (HAP) as an implant material into human periodontal defects. Thirty three patients affected by marginal periodontitis were studied. Following initial therapy, 44 periodon
Autor:
Satoshi Ikeda, Seiji Koga, Koji Maemura, Sanae Kojima, Katsunori Yanagihara, Takako Minami, Miyuki Eto, Tomoo Nakata, Takeo Yoshida, Akira Tsuneto
Publikováno v:
Life Sciences. (25-26):e49-e50